Infections with specific high risk types of human papillomavirus (HPV) constitute a major risk factor for the development of precancerous and cancerous lesions of the uterine cervix. Laboratory studies suggest a mechanistic role of certain types of human papillomaviruses for the development of these lesions. As a consequence of the frequent integration of the HPV genome during carcinogenic progression, the only two viral proteins that are consistently expressed in the anogenital cancer are E6 and E7. They both have transforming properties in vitro, and together they are the only viral factors that are necessary for the immortalization of human genital keratinocytes. This proposal is focussed on the high risk HPV E7 genes, which encode zinc binding nuclear phosphoproteins of approximately 100 amino acid in size with structural and functional similarities to the adenovirus (Ad) E1A protein and the large tumor antigen of the simian virus 40 (SV40 TAg). Similar to these other DNA tumor virus oncoproteins, the high risk HPV E7 proteins exert at least part of their biological functions by interacting with and functionally inactivating the """"""""pocket proteins"""""""", a family of cellular regulators including the retinoblastoma tumor suppressor protein pRB, p 107 and p 130. Although the functional inactivation of the regulatory pathways governed by the pocket proteins may constitute one step in carcinogenesis, there are additional biological and biochemical properties of E7 that may be mediated by different pathways. This grant proposal seeks to uncover such cellular regulatory circuits by defining the molecular basis for two important biological functions of the HPV E7 protein. (1) I will determine the functional domains of the HPV E7 protein that are necessary for the immortalization of primary human genital epithelial cells, the normal host cells of the high risk HPVs. (2) I will define the molecular basis for the ability of HPV E7 to abrogate cell cycle checkpoint control. These proposed experiments are based on our preliminary results that suggest that E7 can interfere with the functions of the cell cycle kinase inhibitor p21cip1. Thus, the ultimate goal of the proposed studies is to identify and characterize on a molecular and biochemical level key regulatory processes that are subverted by an HPV infection and contribute to cellular immortalization and ultimately to carcinogenic progression. This will help the rational deign for intervention and prevention of HPV associated disease and cancer in the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA066980-04
Application #
2871855
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
1996-04-19
Project End
2000-06-30
Budget Start
1999-02-01
Budget End
2000-06-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Harvard University
Department
Pathology
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
McBride, Alison A; Münger, Karl (2018) Expert Views on HPV Infection. Viruses 10:
Liu, Zhiyi; Pouli, Dimitra; Alonzo, Carlo A et al. (2018) Mapping metabolic changes by noninvasive, multiparametric, high-resolution imaging using endogenous contrast. Sci Adv 4:eaap9302
Chiang, Cindy; Pauli, Eva-Katharina; Biryukov, Jennifer et al. (2018) The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling. J Virol 92:
Gaglia, Marta M; Munger, Karl (2018) More than just oncogenes: mechanisms of tumorigenesis by human viruses. Curr Opin Virol 32:48-59
Meyers, Jordan M; Grace, Miranda; Uberoi, Aayushi et al. (2018) Inhibition of TGF-? and NOTCH Signaling by Cutaneous Papillomaviruses. Front Microbiol 9:389
Sharma, Surendra; Munger, Karl (2018) Expression of the cervical carcinoma expressed PCNA regulatory (CCEPR) long noncoding RNA is driven by the human papillomavirus E6 protein and modulates cell proliferation independent of PCNA. Virology 518:8-13
Wallace, Nicholas A; Münger, Karl (2018) The curious case of APOBEC3 activation by cancer-associated human papillomaviruses. PLoS Pathog 14:e1006717
Miller, Anna K; Munger, Karl; Adler, Frederick R (2017) A Mathematical Model of Cell Cycle Dysregulation Due to Human Papillomavirus Infection. Bull Math Biol 79:1564-1585
Harden, Mallory E; Prasad, Nripesh; Griffiths, Anthony et al. (2017) Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins. MBio 8:
Grace, Miranda; Munger, Karl (2017) Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins. Virology 500:71-81

Showing the most recent 10 out of 78 publications